EZH2 and acute myeloid leukemia: Reduced EZH2 and H3K27me3 levels, resulting in reduced CD34+CD38- LSC numbers. In combination with panabinostat, synergistic induction of apoptosis in AML cells, while sparing normal CD34-positive BM progenitor cells.